⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VOR News
Vor Biopharma Inc. Common Stock
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VOR
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
VOR
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
globenewswire.com
VOR
Form 8-K
sec.gov
VOR
Vor Bio Announces $75 Million Private Placement with TCGX
globenewswire.com
VOR
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VOR
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
globenewswire.com
VOR
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
VOR
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
globenewswire.com
VOR